Navigating Changes in the Life Sciences Landscape to Leverage the Value of IP
Intellectual property is central to the development, commercialisation and protection of innovations within the life sciences sector. However, the long development times and complex ideas we see in the field brings about unique challenges and regulatory burdens.
On 8th November 2023, the IP Collective Virtual Roundtables will be bringing together 60+ Heads and Directors of IP from pharmaceutical, biotechnology, medical device and other life science organizations from across North America for a series of interactive discussions on business critical topics such as:
How to highlight the value of IP to the wider business and improve IP as a business asset
Harnessing the power of trade secrets
Discussing key case laws on patent eligibility, the written description and the enablement requirements
Exploring the intersection of AI, Life Sciences and IP
Examining the pressures and opportunities around drug pricing
Request a copy of the full agenda below.
Session leaders include:
What to expect:
“The format worked very well - this is easily the conference that I have gotten the most out of in years (also counting countless "in-person" meetings). The roundtable discussions worked extremely well and the topics were very relevant to me and I got a lot of inspiration for my work. - VP Intellectual Property, Fortune 50 Company
“The round tables were informative and illuminating – I learned a lot and have made some good connections that will be mutually beneficial. Thanks for a great event!” - VP, Global Head Pharma Patents and Policy, Fortune 500 Company
“I thoroughly enjoyed the roundtables, and I found it great to interact with colleagues from other companies. I learned a lot and it was great fun!” - Senior IP Counsel, Biotech Company